GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » Days Sales Outstanding

Joinn Laboratories (China) Co (SHSE:603127) Days Sales Outstanding : 55.60 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co Days Sales Outstanding?

Joinn Laboratories (China) Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥198 Mil. Joinn Laboratories (China) Co's Revenue for the three months ended in Mar. 2024 was ¥325 Mil. Hence, Joinn Laboratories (China) Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 55.60.

The historical rank and industry rank for Joinn Laboratories (China) Co's Days Sales Outstanding or its related term are showing as below:

SHSE:603127' s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.64   Med: 30.12   Max: 43.98
Current: 27.71

During the past 12 years, Joinn Laboratories (China) Co's highest Days Sales Outstanding was 43.98. The lowest was 23.64. And the median was 30.12.

SHSE:603127's Days Sales Outstanding is ranked better than
91.36% of 220 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.345 vs SHSE:603127: 27.71

Joinn Laboratories (China) Co's Days Sales Outstanding increased from Mar. 2023 (45.78) to Mar. 2024 (55.60).


Joinn Laboratories (China) Co Days Sales Outstanding Historical Data

The historical data trend for Joinn Laboratories (China) Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co Days Sales Outstanding Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.31 31.27 23.64 24.71 31.14

Joinn Laboratories (China) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.78 23.70 25.25 20.91 55.60

Competitive Comparison of Joinn Laboratories (China) Co's Days Sales Outstanding

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Days Sales Outstanding falls into.



Joinn Laboratories (China) Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Joinn Laboratories (China) Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (199.437 + 206.014) / 2 ) / 2376.487*365
=202.7255 / 2376.487*365
=31.14

Joinn Laboratories (China) Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (206.014 + 189.795) / 2 ) / 324.809*365 / 4
=197.9045 / 324.809*365 / 4
=55.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Joinn Laboratories (China) Co  (SHSE:603127) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Joinn Laboratories (China) Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Joinn Laboratories (China) Co (SHSE:603127) Business Description

Traded in Other Exchanges
Address
A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Executives
Yao Da Lin Director
Sun Yun Xia Director
Zuo Cong Lin Director
Gao Da Peng Director
Li Ye Supervisors
Gu Xiao Lei Director
Feng Yu Xia Director
Gu Jing Liang senior management
Yu Ai Shui senior management
Yin Li Li Supervisors
Sun Hui Ye Supervisors
Gu Mei Fang Director

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines